EP 0831795 A2 19980401 - PHOSPHATASE INHIBITORS
Title (en)
PHOSPHATASE INHIBITORS
Title (de)
PHOSPHATASE INHIBITOREN
Title (fr)
INHIBITEURS DE LA PHOSPHATASE
Publication
Application
Priority
- US 9609960 W 19960607
- US 47613795 A 19950607
Abstract (en)
[origin: WO9640113A2] The present invention relates to organic molecules capable of inhibiting protein tyrosine phosphatase activity. The invention further relates to the use of such molecules to modulate or regulate signal transduction by inhibiting protein tyrosine phosphatase activity. Finally, the invention relates to the use of such molecules to treat various disease states including diabetes mellitus.
IPC 1-7
A61K 31/00; A61K 31/135; A61K 31/22; A61K 31/34; A61K 31/35; A61K 31/38; A61K 31/41; A61K 31/42; A61K 31/425; A61K 31/44; A61K 31/53; A61K 31/55
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/215 (2006.01); A61K 31/22 (2006.01); A61K 31/222 (2006.01); A61K 31/341 (2006.01); A61K 31/352 (2006.01); A61K 31/381 (2006.01); A61K 31/42 (2006.01); A61K 31/426 (2006.01); A61K 31/433 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/53 (2006.01); A61K 31/55 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/215 (2013.01); A61K 31/22 (2013.01); A61K 31/222 (2013.01); A61K 31/341 (2013.01); A61K 31/352 (2013.01); A61K 31/381 (2013.01); A61K 31/42 (2013.01); A61K 31/426 (2013.01); A61K 31/433 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/53 (2013.01); A61K 31/55 (2013.01)
Citation (search report)
See references of WO 9640113A2
Designated contracting state (EPC)
CH DE FR GB IT LI
DOCDB simple family (publication)
WO 9640113 A2 19961219; WO 9640113 A3 19970123; AU 6110496 A 19961230; EP 0831795 A2 19980401
DOCDB simple family (application)
US 9609960 W 19960607; AU 6110496 A 19960607; EP 96918441 A 19960607